Benin vs Libya: Incidence of tuberculosis, high uncertainty bound
Benin
83 per 100,000 people
in 2011
Libya
48 per 100,000 people
in 2011
Benin rank
45th
Libya rank
48th
Incidence of tuberculosis, high uncertainty bound over time
- Benin
- Libya
How they compare
Benin currently reports 83 per 100,000 people against 48 per 100,000 people in Libya, a difference of 35 per 100,000 people.
That makes Benin's figure about 1.7 times Libya's.
Across all 22 years both countries report, Benin has been ahead every year.
Benin ranks 45th and Libya ranks 48th of 53 countries.
Benin has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Benin | Libya | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 124.3 per 100,000 people | 48 per 100,000 people | 76.3 per 100,000 people | Benin |
| 2000s | 90 per 100,000 people | 47.5 per 100,000 people | 42.5 per 100,000 people | Benin |
| 2010s | 82.5 per 100,000 people | 48 per 100,000 people | 34.5 per 100,000 people | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, high uncertainty bound, Benin or Libya?
- Benin, at 83 per 100,000 people against 48 per 100,000 people in Libya as of 2011.
- What is the difference in incidence of tuberculosis, high uncertainty bound between Benin and Libya?
- 35 per 100,000 people, with Benin ahead.
- How many years of comparable data are there for Benin and Libya?
- 22 years are reported by both, from 1990 to 2011.
- How do Benin and Libya rank globally for incidence of tuberculosis, high uncertainty bound?
- Benin ranks 45th and Libya ranks 48th of 53 countries.
- Where does this data come from?
- World Health Organization, Global Tuberculosis Control Report, published as Incidence of tuberculosis, high uncertainty bound (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new pulmonary, smear positive, and extra-pulmonary tuberculosis cases.